Restart Life Sciences Corp.CSE: HEAL

Restart Life Sciences Details Next-Generation Product Pipeline and Segment Expansion for Holy Crap

· Issued by Restart Life Sciences Corp. via Newsfile

Vancouver, British Columbia--(Newsfile Corp. - July 8, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to provide an update on its forward-looking product development and segment expansion roadmap for its wholly owned subsidiary, Holy Crap Foods Inc.

Following the Company's recent disclosure of its preliminary June 2026 financial growth highlights, management is working to build upon this operational trajectory by systematically diversifying the Holy Crap brand into specialized consumer demographics.

Following the successful completion of its market research and conceptual design phases, the Company has advanced into formulation testing for a new product line targeting the premium youth breakfast sector. Management has identified a high-growth opportunity to capture market share within this demographic by introducing a family-centric packaging strategy. This expansion is engineered to complement Holy Crap's core product portfolio while securing incremental, multi-placement shelf space across both conventional and natural grocery retail channels.

The expansion into the youth category aligns with shifting consumer behavior within the broader breakfast sector:

  • According to data from Statista's Worldwide Breakfast Cereals Industry Report, the global breakfast cereal market is valued at approximately USD $44.3 billion, with family households generating over 52% of total category consumption.

  • Driven by parental demand for clean-label options, health-focused and low-sugar cereal alternatives have experienced a targeted growth rate exceeding 21%, with more than 55% of health-conscious buyers actively seeking certified low-sugar and gluten-free formulations, as noted in recent Grand View Research organic food sector analyses.

Concurrently, the Company's formulation team is developing a senior-specific product(s) to capture a mature demographic previously unaddressed by the brand's existing product architecture. The proposed formulation will focus heavily on targeted digestive health, ingredient bioavailability, and metabolic support tailored to the aging population.

The addressable market parameters for senior-focused functional breakfast nutrition indicate substantial commercial scope:

  • The addressable market parameters for senior-focused functional breakfast nutrition indicate substantial commercial scope. According to a market study by Fortune Business Insights (Geriatric Nutrition Market Analysis), the global senior adult nutrition market was valued at USD $21.1 billion and is projected to expand to USD $29.6 billion, reflecting a steady compound annual growth rate (CAGR) of 5.8%.

  • Within North America, the segment is highly developed due to an established healthcare infrastructure and an elevated awareness of preventive, gut-friendly nutrition as a critical driver of healthy aging.

Earlier from Restart Life Sciences

All Restart Life Sciences news releases